PROM1 and cervical cancer: In conclusion, we identified increased frequencies of a subpopulation of CD49f+ CD133+ cytokeratin+ CD45− CTCs in the blood of patients with vulvar or cervical cancer after adjuvant radiotherapy as well as adjuvant or primary chemoradiotherapy.